The global allergy diagnostics & therapeutics market was estimated at USD 41.19 billion in 2024 and is projected to increase further over the forecast period of 2025-2034 at a CAGR of 6.5%.
Base Year
Historical Year
Forecast Year
Rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, are anticipated to drive the industry growth of the allergy diagnostics & therapeutics in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The allergy diagnostics & therapeutics market can be divided on the basis of segments like product, allergen type, end-use, diagnostic tests, and drug class.
The industry can be broadly categorised on the basis of product into:
The industry can be categorised on the basis of allergen type into:
The industry can be divided based on end-uses into:
The industry can be divided on the basis of diagnostic tests as:
The industry can be segmented based on drug class as:
Looks into the regional markets of allergy diagnostics & therapeutics like:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growth of the allergy diagnostics & therapeutics industry is expected to be driven by a number of factors, such as the high incidence and high economic burden of allergic diseases, increased healthcare spending, and increased access to medical insurance in the United States. Within allergy testing, factors such as widespread availability and high consumption of assay kits are expected to drive the development of this segment in the following years. The category of inhaled allergens is projected to represent the largest share of the market for allergy diagnostics in the forecast period. Increasing environmental pollution is one of the main factors driving the market growth. Growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance are the key factors accelerating the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global allergy diagnostics & therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global allergy diagnostics and therapeutics market attained a value of nearly USD 41.19 billion in 2023.
The market is projected to grow at a CAGR of 6.5% between 2024 and 2032.
The major drivers of the market include rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, growing investments, and the rising research activities.
The increasing acceptance from the United States for allergy treatment via medical insurance are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The product type in the market includes instruments, consumables, and services.
Allergens can be divided into food, inhaled, and drug, among others. Inhaled allergen is the dominant type of allergy diagnostics and therapeutics in the industry.
End uses can be divided into diagnostics labs, hospitals, and academic research institutes.
In-vivo, skin prick test, intradermal, patch test, and in-vitro are the major diagnostic tests in this industry.
The major players in the industry are GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., and Siemens Healthcare GmbH, among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Allergen Type |
|
| Breakup by End Use |
|
| Breakup by Diagnostic Tests |
|
| Breakup by Drug Class |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share